Citation 1:
    Title: AbbVie - 13 Year Stock Price History | ABBV | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/ABBV/abbvie/stock-price-history#:~:text=Sector%20%20,pharma%20companies%20after%20it%20acquired
    Location: chars 160–322

Citation 2:
    Title: AbbVie lifts annual profit forecast on strong demand for newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-annual-profit-forecast-strong-demand-newer-immunology-drugs-2025-07-31/#:~:text=expectations%20for%20its%20second,helps%20counterbalance%20declining%20revenue%20from
    Location: chars 1069–1328

Citation 3:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=%2A%20Second,180%20Billion
    Location: chars 1381–1524

Citation 4:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=,Through%20the%20Second%20Quarter%202025
    Location: chars 1623–1780

Citation 5:
    Title: AbbVie cuts 2025 profit forecast on acquisition expenses
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-cuts-2025-profit-forecast-acquisition-expenses-2025-04-03/#:~:text=acquiring%20firms%20to%20strengthen%20its,The%20company%20now
    Location: chars 1978–2194

Citation 6:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=policy%20changes,premarket%20trading%20following%20the%20announcement
    Location: chars 2426–2661

Citation 7:
    Title: AbbVie to buy Capstan Therapeutics for up to $2.1 billion
    URL: https://www.reuters.com/legal/transactional/abbvie-buy-capstan-therapeutics-up-21-billion-2025-06-30/#:~:text=AbbVie%2C%20a%20U.S.,This
    Location: chars 2749–2905

Citation 8:
    Title: Stock information | AbbVie
    URL: https://investors.abbvie.com/stock-information/stock-quote#:~:text=Total%20dividends%20in%202025%3A%20,U.S.%20Currency
    Location: chars 2993–3137

Citation 9:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=Long,33%2C276
    Location: chars 3232–3355

Citation 10:
    Title: AbbVie says Robert Michael to replace Richard Gonzalez as CEO in July
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-says-richard-gonzalez-step-down-ceo-2024-02-20/#:~:text=AbbVie%20announced%20that%20Chief%20Operating,AbbVie%E2%80%99s%20revenue%20nearly%20tripled%2C%20largely
    Location: chars 3838–4086

Citation 11:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L2840%20performance%20in,on%20a%20constant%20currency%20basis
    Location: chars 4724–4908

Citation 12:
    Title: AbbVie cuts 2025 profit forecast on acquisition expenses
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-cuts-2025-profit-forecast-acquisition-expenses-2025-04-03/#:~:text=acquiring%20firms%20to%20strengthen%20its,The%20company%20now
    Location: chars 5251–5467

Citation 13:
    Title: AbbVie to buy Capstan Therapeutics for up to $2.1 billion
    URL: https://www.reuters.com/legal/transactional/abbvie-buy-capstan-therapeutics-up-21-billion-2025-06-30/#:~:text=AbbVie%2C%20a%20U.S.,This
    Location: chars 5468–5624

Citation 14:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=%2A%20Second,Net%20Revenues%20Were%20%24605%20Million
    Location: chars 6013–6183

Citation 15:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=%2A%20Second,%2411.87%20to
    Location: chars 6224–6367

Citation 16:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=%2A%20Second,180%20Billion
    Location: chars 7200–7343

Citation 17:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=,Through%20the%20Second%20Quarter%202025
    Location: chars 7458–7615

Citation 18:
    Title: AbbVie to buy Capstan Therapeutics for up to $2.1 billion
    URL: https://www.reuters.com/legal/transactional/abbvie-buy-capstan-therapeutics-up-21-billion-2025-06-30/#:~:text=AbbVie%2C%20a%20U.S.,This
    Location: chars 7879–8035

Citation 19:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L2840%20performance%20in,on%20a%20constant%20currency%20basis
    Location: chars 8261–8445

Citation 20:
    Title: Stock information | AbbVie
    URL: https://investors.abbvie.com/stock-information/stock-quote#:~:text=Total%20dividends%20in%202025%3A%20,U.S.%20Currency
    Location: chars 8514–8658

Citation 21:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=%2A%20Second,180%20Billion
    Location: chars 8934–9077

Citation 22:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=Long,33%2C276
    Location: chars 9340–9463

Citation 23:
    Title: AbbVie lifts annual profit forecast on strong demand for newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-annual-profit-forecast-strong-demand-newer-immunology-drugs-2025-07-31/#:~:text=Since%202023%2C%20AbbVie%20has%20invested,The%20company%20now%20anticipates%20adjusted
    Location: chars 9889–10149

Citation 24:
    Title: AbbVie says Robert Michael to replace Richard Gonzalez as CEO in July
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-says-richard-gonzalez-step-down-ceo-2024-02-20/#:~:text=to%20over%20%24300%20billion%2C%20with,been%20with%20AbbVie%20since%20its
    Location: chars 10728–10945

Citation 25:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=from%20several%20major%20products,products%20in%20the%20United%20States
    Location: chars 11111–11292

Citation 26:
    Title: AbbVie lifts annual profit forecast on strong demand for newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-annual-profit-forecast-strong-demand-newer-immunology-drugs-2025-07-31/#:~:text=Since%202023%2C%20AbbVie%20has%20invested,The%20company%20now%20anticipates%20adjusted
    Location: chars 12990–13250

Citation 27:
    Title: AbbVie says Robert Michael to replace Richard Gonzalez as CEO in July
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-says-richard-gonzalez-step-down-ceo-2024-02-20/#:~:text=to%20over%20%24300%20billion%2C%20with,been%20with%20AbbVie%20since%20its
    Location: chars 13890–14107

Citation 28:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=Long,33%2C276
    Location: chars 14421–14544

Citation 29:
    Title: Stock information | AbbVie
    URL: https://investors.abbvie.com/stock-information/stock-quote#:~:text=Total%20dividends%20in%202025%3A%20,U.S.%20Currency
    Location: chars 14705–14849

Citation 30:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L2840%20performance%20in,on%20a%20constant%20currency%20basis
    Location: chars 15706–15890

Citation 31:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L2840%20performance%20in,on%20a%20constant%20currency%20basis
    Location: chars 15898–16082

Citation 32:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L2840%20performance%20in,on%20a%20constant%20currency%20basis
    Location: chars 16090–16274

Citation 33:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L4094%20Operating%20earnings,2%2C448
    Location: chars 16359–16518

Citation 34:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L4094%20Operating%20earnings,2%2C448
    Location: chars 16526–16685

Citation 35:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L4094%20Operating%20earnings,2%2C448
    Location: chars 16693–16852

Citation 36:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=Basic%20earnings%20per%20share%20attributable,6.63
    Location: chars 16937–17097

Citation 37:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=Basic%20earnings%20per%20share%20attributable,6.63
    Location: chars 17106–17266

Citation 38:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=Basic%20earnings%20per%20share%20attributable,6.63
    Location: chars 17275–17435

Citation 39:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L2840%20performance%20in,on%20a%20constant%20currency%20basis
    Location: chars 17543–17727

Citation 40:
    Title: AbbVie Inc. ESG Rating & Sustainability Profile | KnowESG
    URL: https://knowesg.com/esg-ratings/abbvie-inc#:~:text=Net%20Zero
    Location: chars 18395–18473

Citation 41:
    Title: AbbVie says Robert Michael to replace Richard Gonzalez as CEO in July
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-says-richard-gonzalez-step-down-ceo-2024-02-20/#:~:text=to%20over%20%24300%20billion%2C%20with,been%20with%20AbbVie%20since%20its
    Location: chars 19799–20016

Citation 42:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=from%20several%20major%20products,products%20in%20the%20United%20States
    Location: chars 20017–20198

Citation 43:
    Title: AbbVie lifts annual profit forecast on strong demand for newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-annual-profit-forecast-strong-demand-newer-immunology-drugs-2025-07-31/#:~:text=expectations%20for%20its%20second,helps%20counterbalance%20declining%20revenue%20from
    Location: chars 20834–21093

Citation 44:
    Title: AbbVie lifts annual profit forecast on strong demand for newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-annual-profit-forecast-strong-demand-newer-immunology-drugs-2025-07-31/#:~:text=Since%202023%2C%20AbbVie%20has%20invested,U.S.%20trade%20deal
    Location: chars 21094–21329

Citation 45:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=AbbVie%20has%20projected%20higher,over%20%2431%20billion%20by%202027
    Location: chars 21433–21680

Citation 46:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=AbbVie%20%28ABBV,In%20response
    Location: chars 21784–21980

Citation 47:
    Title: AbbVie cuts 2025 profit forecast on acquisition expenses
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-cuts-2025-profit-forecast-acquisition-expenses-2025-04-03/#:~:text=AbbVie%20has%20revised%20its%202025,The%20company%20now
    Location: chars 22069–22279

Citation 48:
    Title: AbbVie to buy Capstan Therapeutics for up to $2.1 billion
    URL: https://www.reuters.com/legal/transactional/abbvie-buy-capstan-therapeutics-up-21-billion-2025-06-30/#:~:text=AbbVie%2C%20a%20U.S.,This
    Location: chars 22370–22526

Citation 49:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=%2A%20Second,180%20Billion
    Location: chars 22617–22760

Citation 50:
    Title: AbbVie Reports Second-Quarter 2025 Financial Results - Jul 31, 2025
    URL: https://news.abbvie.com/2025-07-31-AbbVie-Reports-Second-Quarter-2025-Financial-Results#:~:text=,Through%20the%20Second%20Quarter%202025
    Location: chars 22761–22918

Citation 51:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=match%20at%20L2840%20performance%20in,on%20a%20constant%20currency%20basis
    Location: chars 23016–23200

Citation 52:
    Title: abbv-20241231
    URL: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm#:~:text=Basic%20earnings%20per%20share%20attributable,6.63
    Location: chars 23201–23361

Citation 53:
    Title: Stock information | AbbVie
    URL: https://investors.abbvie.com/stock-information/stock-quote#:~:text=Total%20dividends%20in%202025%3A%20,U.S.%20Currency
    Location: chars 23454–23598

Citation 54:
    Title: AbbVie Inc. ESG Rating & Sustainability Profile | KnowESG
    URL: https://knowesg.com/esg-ratings/abbvie-inc#:~:text=Net%20Zero
    Location: chars 23657–23735

